IRIS
BELLISAI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.281
EU - Europa 3.691
AS - Asia 1.982
SA - Sud America 315
AF - Africa 52
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 11.334
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.217
RU - Federazione Russa 933
SG - Singapore 795
CN - Cina 694
GB - Regno Unito 684
IE - Irlanda 538
SE - Svezia 349
BR - Brasile 284
DE - Germania 279
UA - Ucraina 267
IT - Italia 235
FR - Francia 168
HK - Hong Kong 155
FI - Finlandia 118
KR - Corea 99
VN - Vietnam 74
IN - India 45
CA - Canada 37
ES - Italia 29
CI - Costa d'Avorio 20
MX - Messico 16
BD - Bangladesh 14
AR - Argentina 13
BE - Belgio 13
CZ - Repubblica Ceca 13
IQ - Iraq 13
JP - Giappone 13
PL - Polonia 13
ZA - Sudafrica 12
AT - Austria 11
NL - Olanda 11
IR - Iran 10
PK - Pakistan 10
TR - Turchia 9
UZ - Uzbekistan 9
AU - Australia 8
MA - Marocco 7
LT - Lituania 6
SA - Arabia Saudita 6
IL - Israele 5
NP - Nepal 5
BG - Bulgaria 4
EG - Egitto 4
GR - Grecia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
JM - Giamaica 3
KE - Kenya 3
PH - Filippine 3
TN - Tunisia 3
AM - Armenia 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
CH - Svizzera 2
CL - Cile 2
CU - Cuba 2
EE - Estonia 2
EU - Europa 2
IM - Isola di Man 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PY - Paraguay 2
RO - Romania 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GY - Guiana 1
HU - Ungheria 1
ID - Indonesia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
NC - Nuova Caledonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
UG - Uganda 1
VE - Venezuela 1
Totale 11.334
Salva come PNG Salva come JPEG
Città #
Dallas 920
Menlo Park 806
Southend 599
Singapore 565
Dublin 528
Ashburn 371
Fairfield 364
Chandler 293
Moscow 258
Santa Clara 250
Jacksonville 206
Beijing 195
Woodbridge 180
Hong Kong 154
Wilmington 140
Houston 138
Seattle 134
Ann Arbor 118
Cambridge 112
Hefei 102
Princeton 99
Seoul 98
Munich 80
New York 77
Nanjing 74
Los Angeles 60
Siena 60
Helsinki 42
The Dalles 42
San Mateo 38
Boardman 37
Dearborn 35
Milan 30
São Paulo 30
Buffalo 29
Turku 26
Nanchang 25
San Diego 24
Ho Chi Minh City 21
Shanghai 21
Abidjan 20
London 19
Düsseldorf 18
Columbus 17
Málaga 17
Stockholm 16
Chicago 15
Frankfurt am Main 15
Shenyang 15
Bengaluru 14
Dong Ket 14
Hebei 14
Venezia 14
Washington 14
Brussels 13
Denver 13
Hanoi 13
San Francisco 13
Warsaw 13
Brooklyn 12
Changsha 12
Jinan 12
Redondo Beach 12
Rio de Janeiro 12
Rome 12
Tianjin 12
Tokyo 12
Guangzhou 11
Montreal 11
Atlanta 10
Council Bluffs 10
Florence 10
Toronto 10
Ningbo 9
Vienna 9
Belo Horizonte 8
Brno 8
Phoenix 8
Portsmouth 8
Tashkent 8
Fremont 7
Kunming 7
Lappeenranta 7
Mumbai 7
Norwalk 7
Nuremberg 7
Jiaxing 6
Mestre 6
Mexico City 6
Baghdad 5
Boston 5
Haiphong 5
Hanover 5
Johannesburg 5
Naples 5
Orem 5
Pittsburgh 5
Poplar 5
Querétaro 5
Vancouver 5
Totale 7.999
Salva come PNG Salva come JPEG
Nome #
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 309
High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus 276
Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis 273
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations 270
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 266
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis 264
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 259
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection 259
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 256
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients 241
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 239
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 237
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease 231
Chromosomal abnormalities in peripheral lymphocytes from idiopathic Raynaud's phenomenon patients 231
Anticardiolipin and antibeta2GPI antibodies In a large series of european patients with systemic lupus erythematosus: prevalence and clinical association 230
Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients 228
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 223
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments 222
Chromosome aberrations in Raynaud's phenomenon 221
Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection 216
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 215
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 212
Relationship between serum comp levels and serological markers of disease activity in rheumatoid arthritis patients treated with anti-tnf drugs. A study of the best way to manage indicators of response to therapy 209
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 206
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? 201
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis 195
Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension 190
Prevalence of anti-Histone antibodies, their clinical significante and correlation with other autoantibodies in a color of italian scleroderma patients 188
Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulin 183
Exploring the crosstalk between hydrostatic pressure and adipokines: an in vitro study on human osteoarthritic chondrocytes 182
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 181
HCV e malattie autoimmuni 174
Anterior chest wall non-traumatic diseases: A road map for the radiologist 172
HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus 170
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 165
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 163
Peripheral Macrovascular Involvement in Systemic Sclerosis: A Cohort Study by Color and Spectral Doppler Ultrasonography 162
Coexistence of the antiphospholipid syndrome and abdominal aortic aneurysm 162
Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders 160
HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with SLE 156
Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis 155
Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon 154
Treatment strategies for apatient with rheumatoid arthritis and hepatitis C 153
Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection 152
Incidental findings of anti-mitochondrial antibodies without evidence of Primary Biliary Cholangitis. 152
Bone-sparing effects of rituximab and body composition analysis in a cohort of postmenopausal women affected by rheumatoid arthritis – retrospective study 151
Simultaneouspulmonary involvement, histologically proven, of sarcoidosis and rheumatoidarthritis. 142
Anti-dense fine speckled 70 antibodies in primary Sjögren's syndrome 142
Clinical, laboratory and ultrasonographic findings at baseline predict long-term outcome of polymyalgia rheumatica: a multicentric retrospective study : Polymyalgia rheumatica predicted by ultrasonographic findings polymyalgia rheumatica outcome predicted early by ultrasound 140
Associazione interferon α2b e ciclosporina A nel trattamento dell'epatite cronica C: Trial controllato 137
Efficacy and safety of anti-TNF-alpha therapy combined with cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C virus infection 135
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicenter prospective study of 1000 patients. 134
Interstitial lung disease associated with psoriatic arthritis: a new disease entity? 134
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 132
La tipizzazione genetica nelle malattie reumatiche autoimmuni e nelle sindromi autoinflammatorie 124
The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis 124
Low muscle mass and body composition analysis in a group of postmenopausal women affected by primary Sjögren’s syndrome 122
Le indicazioni al trattamento con immunoglobuline endovena nella sindrome da anticorpi antifosfolipidi. [Indications for intra-venous immunoglobulins treatment in the antiphospholipid syndrome] 115
null 99
Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease 84
Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease 78
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. 78
Totale 11.434
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.294
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021575 0 0 0 0 0 134 28 131 110 44 60 68
2021/2022695 48 79 45 77 27 16 31 20 30 66 89 167
2022/20231.080 68 105 153 150 107 215 16 88 108 22 28 20
2023/2024845 37 16 77 79 28 232 280 9 3 10 11 63
2024/20251.741 35 90 203 82 228 94 66 87 124 82 218 432
2025/20263.360 338 612 760 558 1.055 37 0 0 0 0 0 0
Totale 11.434